Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

Région de Kantō150
Hideki Hasegawa14
Région de Kantō Sauf Hideki Hasegawa" 138
Hideki Hasegawa Sauf Région de Kantō" 2
Région de Kantō Et Hideki Hasegawa 12
Région de Kantō Ou Hideki Hasegawa 152
Corpus10380
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000602 Hanako Sekimukai [Japon] ; Naoko Iwata-Yoshikawa [Japon] ; Shuetsu Fukushi [Japon] ; Hideki Tani [Japon] ; Michiyo Kataoka [Japon] ; Tadaki Suzuki [Japon] ; Hideki Hasegawa [Japon] ; Kenichi Niikura [Japon] ; Katsuhiko Arai [Japon] ; Noriyo Nagata [Japon]Gold nanoparticle-adjuvanted S protein induces a strong antigen-specific IgG response against severe acute respiratory syndrome-related coronavirus infection, but fails to induce protective antibodies and limit eosinophilic infiltration in lungs.
000A85 Naoko Iwata-Yoshikawa [Japon] ; Tadashi Okamura [Japon] ; Yukiko Shimizu [Japon] ; Hideki Hasegawa [Japon] ; Makoto Takeda [Japon] ; Noriyo Nagata [Japon]TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
001655 Naoko Iwata-Yoshikawa [Japon] ; Akihiko Uda [Japon] ; Tadaki Suzuki [Japon] ; Yasuko Tsunetsugu-Yokota [Japon] ; Yuko Sato [Japon] ; Shigeru Morikawa [Japon] ; Masato Tashiro [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon] ; Noriyo Nagata [Japon]Effects of Toll-Like Receptor Stimulation on Eosinophilic Infiltration in Lungs of BALB/c Mice Immunized with UV-Inactivated Severe Acute Respiratory Syndrome-Related Coronavirus Vaccine
002A67 Koji Ishii [Japon] ; Hideki Hasegawa ; Noriyo Nagata ; Yasushi Ami ; Shuetsu Fukushi ; Fumihiro Taguchi ; Yasuko Tsunetsugu-YokotaNeutralizing antibody against severe acute respiratory syndrome (SARS)-coronavirus spike is highly effective for the protection of mice in the murine SARS model.
003486 Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Hideki Hasegawa [Japon] ; Shuetsu Fukushi [Japon] ; Ayako Harashima [Japon] ; Yuko Sato [Japon] ; Masayuki Saijo [Japon] ; Fumihiro Taguchi [Japon] ; Shigeru Morikawa [Japon] ; Tetsutaro Sata [Japon]Mouse-Passaged Severe Acute Respiratory Syndrome-Associated Coronavirus Leads to Lethal Pulmonary Edema and Diffuse Alveolar Damage in Adult but Not Young Mice
003937 Noriyo Nagata ; Naoko Iwata ; Hideki Hasegawa ; Yuko Sato ; Shigeru Morikawa ; Masayuki Saijo ; Shigeyuki Itamura ; Takehiko Saito ; Yasushi Ami [Japon] ; Takato Odagiri ; Masato Tashiro ; Tetsutaro SataPathology and virus dispersion in cynomolgus monkeys experimentally infected with severe acute respiratory syndrome coronavirus via different inoculation routes
003B48 Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Hideki Hasegawa [Japon] ; Shuetsu Fukushi [Japon] ; Masaru Yokoyama [Japon] ; Ayako Harashima [Japon] ; Yuko Sato [Japon] ; Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Tetsutaro Sata [Japon]Participation of both host and virus factors in induction of severe acute respiratory syndrome (SARS) in F344 Rats infected with SARS coronavirus
003D85 Noriyo Nagata [Japon] ; Naoko Iwata ; Hideki Hasegawa ; Yasuko Asahi-Ozaki ; Yuko Sato ; Ayako Harashima ; Shigeru Morikawa ; Masayuki Saijo ; Shigeyuki Itamura ; Takehiko Saito ; Takato Odagiri ; Masato Tashiro ; Yasushi Ami ; Tetsutaro SataPathological and virological analyses of severe acute respiratory syndrome-associated coronavirus infections in experimental animals.
003E50 Koji Ishii [Japon] ; Hideki Hasegawa [Japon] ; Noriyo Nagata [Japon] ; Tetsuya Mizutani [Japon] ; Shigeru Morikawa [Japon] ; Tetsuro Suzuki [Japon] ; Fumihiro Taguchi [Japon] ; Masato Tashiro [Japon] ; Toshitada Takemori [Japon] ; Tatsuo Miyamura [Japon] ; Yasuko Tsunetsugu-Yokota [Japon]Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
003E80 Koji Ishii [Japon] ; Hideki Hasegawa ; Noriyo Nagata ; Tetsuya Mizutani ; Shigeru Morikawa ; Masato Tashiro ; Tetsuro Suzuki ; Fumihiro Taguchi ; Toshitada Takemori ; Tatsuo Miyamura ; Yasuko Tsunetsugu-YokotaHighly attenuated vaccinia virus DIs as a potential SARS vaccine.
004198 Takeshi Ichinohe [Japon] ; Izumi Watanabe [Japon] ; Eriko Tao [Japon] ; Satoshi Ito [Japon] ; Akira Kawaguchi [Japon] ; Shin-Ichi Tamura [Japon] ; Hidehiro Takahashi [Japon] ; Hirofumi Sawa [Japon] ; Masami Moriyama [Japon] ; Joe Chiba [Japon] ; Katsuhiro Komase [Japon] ; Yujiro Suzuki [Japon] ; Takeshi Kurata [Japon] ; Tetsutaro Sata [Japon] ; Hideki Hasegawa [Japon]Protection against influenza virus infection by intranasal vaccine with surf clam microparticles (SMP) as an adjuvant
004E02 Masayuki Saijo [Japon] ; Shigeru Morikawa [Japon] ; Shuetsu Fukushi [Japon] ; Tetsuya Mizutani [Japon] ; Hideki Hasegawa [Japon] ; Noriyo Nagata [Japon] ; Naoko Iwata [Japon] ; Ichiro Kurane [Japon]Inhibitory effect of mizoribine and ribavirin on the replication of severe acute respiratory syndrome (SARS)-associated coronavirus

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021